1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Anti-Parkinson Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Dopaminergic 1.2.3 Dopamine Agonists 1.2.4 Enzyme Inhibitors 1.2.5 Others 1.3 Market by Application 1.3.1 Global Anti-Parkinson Drugs Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital Pharmacy 1.3.3 Retail Pharmacy 1.3.4 Online Stores 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Anti-Parkinson Drugs Market Perspective (2016-2027) 2.2 Anti-Parkinson Drugs Growth Trends by Regions 2.2.1 Anti-Parkinson Drugs Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Anti-Parkinson Drugs Historic Market Share by Regions (2016-2021) 2.2.3 Anti-Parkinson Drugs Forecasted Market Size by Regions (2022-2027) 2.3 Anti-Parkinson Drugs Industry Dynamic 2.3.1 Anti-Parkinson Drugs Market Trends 2.3.2 Anti-Parkinson Drugs Market Drivers 2.3.3 Anti-Parkinson Drugs Market Challenges 2.3.4 Anti-Parkinson Drugs Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Anti-Parkinson Drugs Players by Revenue 3.1.1 Global Top Anti-Parkinson Drugs Players by Revenue (2016-2021) 3.1.2 Global Anti-Parkinson Drugs Revenue Market Share by Players (2016-2021) 3.2 Global Anti-Parkinson Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Anti-Parkinson Drugs Revenue 3.4 Global Anti-Parkinson Drugs Market Concentration Ratio 3.4.1 Global Anti-Parkinson Drugs Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Anti-Parkinson Drugs Revenue in 2020 3.5 Anti-Parkinson Drugs Key Players Head office and Area Served 3.6 Key Players Anti-Parkinson Drugs Product Solution and Service 3.7 Date of Enter into Anti-Parkinson Drugs Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Anti-Parkinson Drugs Breakdown Data by Type 4.1 Global Anti-Parkinson Drugs Historic Market Size by Type (2016-2021) 4.2 Global Anti-Parkinson Drugs Forecasted Market Size by Type (2022-2027) 5 Anti-Parkinson Drugs Breakdown Data by Application 5.1 Global Anti-Parkinson Drugs Historic Market Size by Application (2016-2021) 5.2 Global Anti-Parkinson Drugs Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Anti-Parkinson Drugs Market Size (2016-2027) 6.2 North America Anti-Parkinson Drugs Market Size by Type 6.2.1 North America Anti-Parkinson Drugs Market Size by Type (2016-2021) 6.2.2 North America Anti-Parkinson Drugs Market Size by Type (2022-2027) 6.2.3 North America Anti-Parkinson Drugs Market Size by Type (2016-2027) 6.3 North America Anti-Parkinson Drugs Market Size by Application 6.3.1 North America Anti-Parkinson Drugs Market Size by Application (2016-2021) 6.3.2 North America Anti-Parkinson Drugs Market Size by Application (2022-2027) 6.3.3 North America Anti-Parkinson Drugs Market Size by Application (2016-2027) 6.4 North America Anti-Parkinson Drugs Market Size by Country 6.4.1 North America Anti-Parkinson Drugs Market Size by Country (2016-2021) 6.4.2 North America Anti-Parkinson Drugs Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Anti-Parkinson Drugs Market Size (2016-2027) 7.2 Europe Anti-Parkinson Drugs Market Size by Type 7.2.1 Europe Anti-Parkinson Drugs Market Size by Type (2016-2021) 7.2.2 Europe Anti-Parkinson Drugs Market Size by Type (2022-2027) 7.2.3 Europe Anti-Parkinson Drugs Market Size by Type (2016-2027) 7.3 Europe Anti-Parkinson Drugs Market Size by Application 7.3.1 Europe Anti-Parkinson Drugs Market Size by Application (2016-2021) 7.3.2 Europe Anti-Parkinson Drugs Market Size by Application (2022-2027) 7.3.3 Europe Anti-Parkinson Drugs Market Size by Application (2016-2027) 7.4 Europe Anti-Parkinson Drugs Market Size by Country 7.4.1 Europe Anti-Parkinson Drugs Market Size by Country (2016-2021) 7.4.2 Europe Anti-Parkinson Drugs Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Anti-Parkinson Drugs Market Size (2016-2027) 8.2 Asia-Pacific Anti-Parkinson Drugs Market Size by Type 8.2.1 Asia-Pacific Anti-Parkinson Drugs Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Anti-Parkinson Drugs Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Anti-Parkinson Drugs Market Size by Type (2016-2027) 8.3 Asia-Pacific Anti-Parkinson Drugs Market Size by Application 8.3.1 Asia-Pacific Anti-Parkinson Drugs Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Anti-Parkinson Drugs Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Anti-Parkinson Drugs Market Size by Application (2016-2027) 8.4 Asia-Pacific Anti-Parkinson Drugs Market Size by Region 8.4.1 Asia-Pacific Anti-Parkinson Drugs Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Anti-Parkinson Drugs Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Anti-Parkinson Drugs Market Size (2016-2027) 9.2 Latin America Anti-Parkinson Drugs Market Size by Type 9.2.1 Latin America Anti-Parkinson Drugs Market Size by Type (2016-2021) 9.2.2 Latin America Anti-Parkinson Drugs Market Size by Type (2022-2027) 9.2.3 Latin America Anti-Parkinson Drugs Market Size by Type (2016-2027) 9.3 Latin America Anti-Parkinson Drugs Market Size by Application 9.3.1 Latin America Anti-Parkinson Drugs Market Size by Application (2016-2021) 9.3.2 Latin America Anti-Parkinson Drugs Market Size by Application (2022-2027) 9.3.3 Latin America Anti-Parkinson Drugs Market Size by Application (2016-2027) 9.4 Latin America Anti-Parkinson Drugs Market Size by Country 9.4.1 Latin America Anti-Parkinson Drugs Market Size by Country (2016-2021) 9.4.2 Latin America Anti-Parkinson Drugs Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Anti-Parkinson Drugs Market Size (2016-2027) 10.2 Middle East & Africa Anti-Parkinson Drugs Market Size by Type 10.2.1 Middle East & Africa Anti-Parkinson Drugs Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Anti-Parkinson Drugs Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Anti-Parkinson Drugs Market Size by Type (2016-2027) 10.3 Middle East & Africa Anti-Parkinson Drugs Market Size by Application 10.3.1 Middle East & Africa Anti-Parkinson Drugs Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Anti-Parkinson Drugs Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Anti-Parkinson Drugs Market Size by Application (2016-2027) 10.4 Middle East & Africa Anti-Parkinson Drugs Market Size by Country 10.4.1 Middle East & Africa Anti-Parkinson Drugs Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Anti-Parkinson Drugs Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 AbbVie 11.1.1 AbbVie Company Details 11.1.2 AbbVie Business Overview 11.1.3 AbbVie Anti-Parkinson Drugs Introduction 11.1.4 AbbVie Revenue in Anti-Parkinson Drugs Business (2016-2021) 11.1.5 AbbVie Recent Development 11.2 Mylan Laboratories 11.2.1 Mylan Laboratories Company Details 11.2.2 Mylan Laboratories Business Overview 11.2.3 Mylan Laboratories Anti-Parkinson Drugs Introduction 11.2.4 Mylan Laboratories Revenue in Anti-Parkinson Drugs Business (2016-2021) 11.2.5 Mylan Laboratories Recent Development 11.3 Valeant Pharmaceuticals 11.3.1 Valeant Pharmaceuticals Company Details 11.3.2 Valeant Pharmaceuticals Business Overview 11.3.3 Valeant Pharmaceuticals Anti-Parkinson Drugs Introduction 11.3.4 Valeant Pharmaceuticals Revenue in Anti-Parkinson Drugs Business (2016-2021) 11.3.5 Valeant Pharmaceuticals Recent Development 11.4 Novartis 11.4.1 Novartis Company Details 11.4.2 Novartis Business Overview 11.4.3 Novartis Anti-Parkinson Drugs Introduction 11.4.4 Novartis Revenue in Anti-Parkinson Drugs Business (2016-2021) 11.4.5 Novartis Recent Development 11.5 GlaxoSmithKline 11.5.1 GlaxoSmithKline Company Details 11.5.2 GlaxoSmithKline Business Overview 11.5.3 GlaxoSmithKline Anti-Parkinson Drugs Introduction 11.5.4 GlaxoSmithKline Revenue in Anti-Parkinson Drugs Business (2016-2021) 11.5.5 GlaxoSmithKline Recent Development 11.6 Zambon Pharmaceuticals 11.6.1 Zambon Pharmaceuticals Company Details 11.6.2 Zambon Pharmaceuticals Business Overview 11.6.3 Zambon Pharmaceuticals Anti-Parkinson Drugs Introduction 11.6.4 Zambon Pharmaceuticals Revenue in Anti-Parkinson Drugs Business (2016-2021) 11.6.5 Zambon Pharmaceuticals Recent Development 11.7 Pfizer, Inc. 11.7.1 Pfizer, Inc. Company Details 11.7.2 Pfizer, Inc. Business Overview 11.7.3 Pfizer, Inc. Anti-Parkinson Drugs Introduction 11.7.4 Pfizer, Inc. Revenue in Anti-Parkinson Drugs Business (2016-2021) 11.7.5 Pfizer, Inc. Recent Development 11.8 Hoffmann-La Roche 11.8.1 Hoffmann-La Roche Company Details 11.8.2 Hoffmann-La Roche Business Overview 11.8.3 Hoffmann-La Roche Anti-Parkinson Drugs Introduction 11.8.4 Hoffmann-La Roche Revenue in Anti-Parkinson Drugs Business (2016-2021) 11.8.5 Hoffmann-La Roche Recent Development 11.9 Merck & Co. 11.9.1 Merck & Co. Company Details 11.9.2 Merck & Co. Business Overview 11.9.3 Merck & Co. Anti-Parkinson Drugs Introduction 11.9.4 Merck & Co. Revenue in Anti-Parkinson Drugs Business (2016-2021) 11.9.5 Merck & Co. Recent Development 11.10 Orion Pharma 11.10.1 Orion Pharma Company Details 11.10.2 Orion Pharma Business Overview 11.10.3 Orion Pharma Anti-Parkinson Drugs Introduction 11.10.4 Orion Pharma Revenue in Anti-Parkinson Drugs Business (2016-2021) 11.10.5 Orion Pharma Recent Development 11.11 UCB 11.11.1 UCB Company Details 11.11.2 UCB Business Overview 11.11.3 UCB Anti-Parkinson Drugs Introduction 11.11.4 UCB Revenue in Anti-Parkinson Drugs Business (2016-2021) 11.11.5 UCB Recent Development 11.12 Teva Pharmaceutical Industries Ltd. 11.12.1 Teva Pharmaceutical Industries Ltd. Company Details 11.12.2 Teva Pharmaceutical Industries Ltd. Business Overview 11.12.3 Teva Pharmaceutical Industries Ltd. Anti-Parkinson Drugs Introduction 11.12.4 Teva Pharmaceutical Industries Ltd. Revenue in Anti-Parkinson Drugs Business (2016-2021) 11.12.5 Teva Pharmaceutical Industries Ltd. Recent Development 11.13 Vertical Pharmaceuticals, LLC 11.13.1 Vertical Pharmaceuticals, LLC Company Details 11.13.2 Vertical Pharmaceuticals, LLC Business Overview 11.13.3 Vertical Pharmaceuticals, LLC Anti-Parkinson Drugs Introduction 11.13.4 Vertical Pharmaceuticals, LLC Revenue in Anti-Parkinson Drugs Business (2016-2021) 11.13.5 Vertical Pharmaceuticals, LLC Recent Development 11.14 ACADIA Pharmaceuticals Inc. 11.14.1 ACADIA Pharmaceuticals Inc. Company Details 11.14.2 ACADIA Pharmaceuticals Inc. Business Overview 11.14.3 ACADIA Pharmaceuticals Inc. Anti-Parkinson Drugs Introduction 11.14.4 ACADIA Pharmaceuticals Inc. Revenue in Anti-Parkinson Drugs Business (2016-2021) 11.14.5 ACADIA Pharmaceuticals Inc. Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Anti-Parkinson Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Dopaminergic Table 3. Key Players of Dopamine Agonists Table 4. Key Players of Enzyme Inhibitors Table 5. Key Players of Others Table 6. Global Anti-Parkinson Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Anti-Parkinson Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Anti-Parkinson Drugs Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Anti-Parkinson Drugs Market Share by Regions (2016-2021) Table 10. Global Anti-Parkinson Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Anti-Parkinson Drugs Market Share by Regions (2022-2027) Table 12. Anti-Parkinson Drugs Market Trends Table 13. Anti-Parkinson Drugs Market Drivers Table 14. Anti-Parkinson Drugs Market Challenges Table 15. Anti-Parkinson Drugs Market Restraints Table 16. Global Anti-Parkinson Drugs Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Anti-Parkinson Drugs Market Share by Players (2016-2021) Table 18. Global Top Anti-Parkinson Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Parkinson Drugs as of 2020) Table 19. Ranking of Global Top Anti-Parkinson Drugs Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Anti-Parkinson Drugs Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Anti-Parkinson Drugs Product Solution and Service Table 23. Date of Enter into Anti-Parkinson Drugs Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Anti-Parkinson Drugs Market Size by Type (2016-2021) (US$ Million) Table 26. Global Anti-Parkinson Drugs Revenue Market Share by Type (2016-2021) Table 27. Global Anti-Parkinson Drugs Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Anti-Parkinson Drugs Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Anti-Parkinson Drugs Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Anti-Parkinson Drugs Revenue Market Share by Application (2016-2021) Table 31. Global Anti-Parkinson Drugs Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Anti-Parkinson Drugs Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Anti-Parkinson Drugs Market Size by Type (2016-2021) (US$ Million) Table 34. North America Anti-Parkinson Drugs Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Anti-Parkinson Drugs Market Size by Application (2016-2021) (US$ Million) Table 36. North America Anti-Parkinson Drugs Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Anti-Parkinson Drugs Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Anti-Parkinson Drugs Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Anti-Parkinson Drugs Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Anti-Parkinson Drugs Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Anti-Parkinson Drugs Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Anti-Parkinson Drugs Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Anti-Parkinson Drugs Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Anti-Parkinson Drugs Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Anti-Parkinson Drugs Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Anti-Parkinson Drugs Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Anti-Parkinson Drugs Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Anti-Parkinson Drugs Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Anti-Parkinson Drugs Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Anti-Parkinson Drugs Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Anti-Parkinson Drugs Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Anti-Parkinson Drugs Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Anti-Parkinson Drugs Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Anti-Parkinson Drugs Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Anti-Parkinson Drugs Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Anti-Parkinson Drugs Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Anti-Parkinson Drugs Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Anti-Parkinson Drugs Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Anti-Parkinson Drugs Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Anti-Parkinson Drugs Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Anti-Parkinson Drugs Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Anti-Parkinson Drugs Market Size by Country (2022-2027) & (US$ Million) Table 63. AbbVie Company Details Table 64. AbbVie Business Overview Table 65. AbbVie Anti-Parkinson Drugs Product Table 66. AbbVie Revenue in Anti-Parkinson Drugs Business (2016-2021) & (US$ Million) Table 67. AbbVie Recent Development Table 68. Mylan Laboratories Company Details Table 69. Mylan Laboratories Business Overview Table 70. Mylan Laboratories Anti-Parkinson Drugs Product Table 71. Mylan Laboratories Revenue in Anti-Parkinson Drugs Business (2016-2021) & (US$ Million) Table 72. Mylan Laboratories Recent Development Table 73. Valeant Pharmaceuticals Company Details Table 74. Valeant Pharmaceuticals Business Overview Table 75. Valeant Pharmaceuticals Anti-Parkinson Drugs Product Table 76. Valeant Pharmaceuticals Revenue in Anti-Parkinson Drugs Business (2016-2021) & (US$ Million) Table 77. Valeant Pharmaceuticals Recent Development Table 78. Novartis Company Details Table 79. Novartis Business Overview Table 80. Novartis Anti-Parkinson Drugs Product Table 81. Novartis Revenue in Anti-Parkinson Drugs Business (2016-2021) & (US$ Million) Table 82. Novartis Recent Development Table 83. GlaxoSmithKline Company Details Table 84. GlaxoSmithKline Business Overview Table 85. GlaxoSmithKline Anti-Parkinson Drugs Product Table 86. GlaxoSmithKline Revenue in Anti-Parkinson Drugs Business (2016-2021) & (US$ Million) Table 87. GlaxoSmithKline Recent Development Table 88. Zambon Pharmaceuticals Company Details Table 89. Zambon Pharmaceuticals Business Overview Table 90. Zambon Pharmaceuticals Anti-Parkinson Drugs Product Table 91. Zambon Pharmaceuticals Revenue in Anti-Parkinson Drugs Business (2016-2021) & (US$ Million) Table 92. Zambon Pharmaceuticals Recent Development Table 93. Pfizer, Inc. Company Details Table 94. Pfizer, Inc. Business Overview Table 95. Pfizer, Inc. Anti-Parkinson Drugs Product Table 96. Pfizer, Inc. Revenue in Anti-Parkinson Drugs Business (2016-2021) & (US$ Million) Table 97. Pfizer, Inc. Recent Development Table 98. Hoffmann-La Roche Company Details Table 99. Hoffmann-La Roche Business Overview Table 100. Hoffmann-La Roche Revenue in Anti-Parkinson Drugs Business (2016-2021) & (US$ Million) Table 101. Hoffmann-La Roche Recent Development Table 102. Merck & Co. Company Details Table 103. Merck & Co. Business Overview Table 104. Merck & Co. Anti-Parkinson Drugs Product Table 105. Merck & Co. Revenue in Anti-Parkinson Drugs Business (2016-2021) & (US$ Million) Table 106. Merck & Co. Recent Development Table 107. Orion Pharma Company Details Table 108. Orion Pharma Business Overview Table 109. Orion Pharma Anti-Parkinson Drugs Product Table 110. Orion Pharma Revenue in Anti-Parkinson Drugs Business (2016-2021) & (US$ Million) Table 111. Orion Pharma Recent Development Table 112. UCB Company Details Table 113. UCB Business Overview Table 114. UCB Anti-Parkinson Drugs Product Table 115. UCB Revenue in Anti-Parkinson Drugs Business (2016-2021) & (US$ Million) Table 116. UCB Recent Development Table 117. Teva Pharmaceutical Industries Ltd. Company Details Table 118. Teva Pharmaceutical Industries Ltd. Business Overview Table 119. Teva Pharmaceutical Industries Ltd. Anti-Parkinson Drugs Product Table 120. Teva Pharmaceutical Industries Ltd. Revenue in Anti-Parkinson Drugs Business (2016-2021) & (US$ Million) Table 121. Teva Pharmaceutical Industries Ltd. Recent Development Table 122. Vertical Pharmaceuticals, LLC Company Details Table 123. Vertical Pharmaceuticals, LLC Business Overview Table 124. Vertical Pharmaceuticals, LLC Anti-Parkinson Drugs Product Table 125. Vertical Pharmaceuticals, LLC Revenue in Anti-Parkinson Drugs Business (2016-2021) & (US$ Million) Table 126. Vertical Pharmaceuticals, LLC Recent Development Table 127. ACADIA Pharmaceuticals Inc. Company Details Table 128. ACADIA Pharmaceuticals Inc. Business Overview Table 129. ACADIA Pharmaceuticals Inc. Anti-Parkinson Drugs Product Table 130. ACADIA Pharmaceuticals Inc. Revenue in Anti-Parkinson Drugs Business (2016-2021) & (US$ Million) Table 131. ACADIA Pharmaceuticals Inc. Recent Development Table 132. Research Programs/Design for This Report Table 133. Key Data Information from Secondary Sources Table 134. Key Data Information from Primary Sources List of Figures Figure 1. Global Anti-Parkinson Drugs Market Share by Type: 2020 VS 2027 Figure 2. Dopaminergic Features Figure 3. Dopamine Agonists Features Figure 4. Enzyme Inhibitors Features Figure 5. Others Features Figure 6. Global Anti-Parkinson Drugs Market Share by Application: 2020 VS 2027 Figure 7. Hospital Pharmacy Case Studies Figure 8. Retail Pharmacy Case Studies Figure 9. Online Stores Case Studies Figure 10. Anti-Parkinson Drugs Report Years Considered Figure 11. Global Anti-Parkinson Drugs Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Anti-Parkinson Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Anti-Parkinson Drugs Market Share by Regions: 2020 VS 2027 Figure 14. Global Anti-Parkinson Drugs Market Share by Regions (2022-2027) Figure 15. Global Anti-Parkinson Drugs Market Share by Players in 2020 Figure 16. Global Top Anti-Parkinson Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Parkinson Drugs as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Anti-Parkinson Drugs Revenue in 2020 Figure 18. Global Anti-Parkinson Drugs Revenue Market Share by Type (2016-2021) Figure 19. Global Anti-Parkinson Drugs Revenue Market Share by Type (2022-2027) Figure 20. North America Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Anti-Parkinson Drugs Market Share by Type (2016-2027) Figure 22. North America Anti-Parkinson Drugs Market Share by Application (2016-2027) Figure 23. North America Anti-Parkinson Drugs Market Share by Country (2016-2027) Figure 24. United States Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Anti-Parkinson Drugs Market Share by Type (2016-2027) Figure 28. Europe Anti-Parkinson Drugs Market Share by Application (2016-2027) Figure 29. Europe Anti-Parkinson Drugs Market Share by Country (2016-2027) Figure 30. Germany Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Anti-Parkinson Drugs Market Share by Type (2016-2027) Figure 38. Asia-Pacific Anti-Parkinson Drugs Market Share by Application (2016-2027) Figure 39. Asia-Pacific Anti-Parkinson Drugs Market Share by Region (2016-2027) Figure 40. China Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Anti-Parkinson Drugs Market Share by Type (2016-2027) Figure 48. Latin America Anti-Parkinson Drugs Market Share by Application (2016-2027) Figure 49. Latin America Anti-Parkinson Drugs Market Share by Country (2016-2027) Figure 50. Mexico Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Anti-Parkinson Drugs Market Share by Type (2016-2027) Figure 54. Middle East & Africa Anti-Parkinson Drugs Market Share by Application (2016-2027) Figure 55. Middle East & Africa Anti-Parkinson Drugs Market Share by Country (2016-2027) Figure 56. Turkey Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Anti-Parkinson Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. AbbVie Revenue Growth Rate in Anti-Parkinson Drugs Business (2016-2021) Figure 60. Mylan Laboratories Revenue Growth Rate in Anti-Parkinson Drugs Business (2016-2021) Figure 61. Valeant Pharmaceuticals Revenue Growth Rate in Anti-Parkinson Drugs Business (2016-2021) Figure 62. Novartis Revenue Growth Rate in Anti-Parkinson Drugs Business (2016-2021) Figure 63. GlaxoSmithKline Revenue Growth Rate in Anti-Parkinson Drugs Business (2016-2021) Figure 64. Zambon Pharmaceuticals Revenue Growth Rate in Anti-Parkinson Drugs Business (2016-2021) Figure 65. Pfizer, Inc. Revenue Growth Rate in Anti-Parkinson Drugs Business (2016-2021) Figure 66. Hoffmann-La Roche Revenue Growth Rate in Anti-Parkinson Drugs Business (2016-2021) Figure 67. Merck & Co. Revenue Growth Rate in Anti-Parkinson Drugs Business (2016-2021) Figure 68. Orion Pharma Revenue Growth Rate in Anti-Parkinson Drugs Business (2016-2021) Figure 69. UCB Revenue Growth Rate in Anti-Parkinson Drugs Business (2016-2021) Figure 70. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Anti-Parkinson Drugs Business (2016-2021) Figure 71. Vertical Pharmaceuticals, LLC Revenue Growth Rate in Anti-Parkinson Drugs Business (2016-2021) Figure 72. ACADIA Pharmaceuticals Inc. Revenue Growth Rate in Anti-Parkinson Drugs Business (2016-2021) Figure 73. Bottom-up and Top-down Approaches for This Report Figure 74. Data Triangulation Figure 75. Key Executives Interviewed

AbbVie Mylan Laboratories Valeant Pharmaceuticals Novartis GlaxoSmithKline Zambon Pharmaceuticals Pfizer, Inc. Hoffmann-La Roche Merck & Co. Orion Pharma UCB Teva Pharmaceutical Industries Ltd. Vertical Pharmaceuticals, LLC ACADIA Pharmaceuticals Inc.